Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | Q9HBH1 | 4/20 | 0.44 | |
| ▸ | MMP2 | P08253 | 14/20 | 0.36 |
| ▸ | MMP3 | P08254 | 10/20 | 0.36 |
| ▸ | MMP1 | P03956 | 4/20 | 0.36 |
| ▸ | MMP7 | P09237 | 1/20 | 0.36 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
| ▸ | MMP14 | P50281 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7977102 | 1.00 | PDF (0.44) | PDFMMP2MMP3MMP1MMP7 | |
| SCHEMBL7995047 | 0.97 | PDF (0.43) | PDFMMP2MMP3MMP1MMP7 | |
| SCHEMBL7987208 | 0.97 | PDF (0.43) | PDFMMP2MMP3MMP1MMP7 | |
| SCHEMBL7989538 | 0.88 | PDF (0.43) | PDFMMP2MMP3MMP1MMP7 | |
| SCHEMBL7992880 | 0.87 | PDF (0.40) | PDFMMP2MMP3MMP1MMP7 | |
| SCHEMBL7990024 | 0.86 | PDF (0.58) | PDFMMP2MMP3MMP1MMP7 | |
| SCHEMBL7987314 | 0.84 | MME (0.41) | PDFMMP2MMP3MMP1BIRC2 | |
| SCHEMBL7989849 | 0.83 | PDF (0.37) | PDFMMP2MMP3MMP1MMP7 | |
| SCHEMBL7990047 | 0.82 | PDF (0.50) | PDFMMP2MMP3MMP1MMP7 | |
| SCHEMBL7975796 | 0.81 | ALDH1A1 (0.32) |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001040198-A2 | MACROCYCLIC HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS ANTIMICROBIAL AGENTS | AVENTIS PHARMA S.A. (FR) | 2001-06-07 | — | — | WO | disclosed |